Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40.3M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
4.93M
-
Shares change
-
-303K
-
Total reported value, excl. options
-
$77.6M
-
Value change
-
-$4.98M
-
Number of buys
-
4
-
Number of sells
-
-9
-
Price
-
$15.74
Significant Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q3 2021
20 filings reported holding BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share as of Q3 2021.
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.93M shares
of 40.3M outstanding shares and own 12.23% of the company stock.
Largest 10 shareholders include Alphabet Inc. (1.7M shares), M&G INVESTMENT MANAGEMENT LTD (1.09M shares), DC Funds, LP (642K shares), Liontrust Investment Partners LLP (600K shares), Tudor Investment Corp Et Al (378K shares), Hudson Bay Capital Management LP (189K shares), MILLENNIUM MANAGEMENT LLC (118K shares), Ipswich Investment Management Co., Inc. (51.5K shares), Vontobel Holding Ltd. (40K shares), and Arena Capital Advisors, LLC- CA (30.7K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.